Previous Close | 0.3300 |
Open | 0.5700 |
Bid | 0.0100 |
Ask | 0.3000 |
Strike | 260.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.3300 - 0.5700 |
Contract Range | N/A |
Volume | |
Open Interest | 531 |
Stocks of LLY, VKTX and GPCR, which make oral pills for obesity, rose on Wednesday in response to Novo Nordisk's positive data.
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage study.